steveHoffman-prof.jpg

Stephen L. Hoffman

MD, DTMH, DSc (hon), FIDSA, FASTMH, FAAAS, FAAM

Sanaria Inc.

Dr. Hoffman is Chief Executive and Scientific Officer of Sanaria Inc., a company dedicated to developing a whole sporozoite malaria vaccine, a vaccine that won the Vaccine Industry Excellence (VIE) Award in 2015 for “Best Prophylactic Vaccine.” From 1987-2001 he was Director, Malaria Program, Naval Medical Research Center. In 2001 he joined Celera Genomics as Senior VP, Biologics and created a program to utilize genomics/proteomics to produce biopharmaceuticals and personalized medicines. He has held several professorships, is past president of American Society of Tropical Medicine and Hygiene and authored > 435 scientific publications.  He was listed as the third most influential person in the world vaccine industry in 2015, and is a member of the National Academy of Medicine.